scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1032958670 |
P356 | DOI | 10.1038/SJ.ONC.1201851 |
P698 | PubMed publication ID | 9671389 |
P5875 | ResearchGate publication ID | 13614361 |
P2093 | author name string | C D'Sa-Eipper | |
G Chinnadurai | |||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3105-3114 | |
P577 | publication date | 1998-06-01 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities | |
P478 | volume | 16 |
Q28137979 | A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor |
Q38025197 | BCL-2 family of proteins and mammary cellular fate |
Q36419013 | BCL2 family of apoptosis-related genes: functions and clinical implications in cancer |
Q77870361 | Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax |
Q33726917 | Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury |
Q40088689 | Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist |
Q44419390 | Bfl-1S, a novel alternative splice variant of Bfl-1, localizes in the nucleus via its C-terminus and prevents cell death |
Q37431712 | C-terminal residues regulate localization and function of the antiapoptotic protein Bfl-1. |
Q47188887 | Comparison of mammary gland involution between 129S1 and C57BL/6 inbred mouse strains: differential regulation of Bcl2a1, Trp53, Cebpb, and Cebpd expression |
Q40359260 | Constitutive expression of the anti-apoptotic Bcl-2 family member A1 in murine endothelial cells leads to transplant tolerance |
Q40386441 | Constitutive proteasome-mediated turnover of Bfl-1/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor. |
Q48581961 | Cytokines and the molecular mechanisms of alcoholic liver disease |
Q73310307 | Effect of ethanol on tumor necrosis factor signaling during liver regeneration |
Q40217535 | Effect of indomethacin on Bfl-1, WISP-1 and proliferating cell nuclear antigen in colon cancer cell line HCT116 cells |
Q35024009 | Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway |
Q34430361 | Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice |
Q38299128 | Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation |
Q39901400 | Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line |
Q50476595 | IgE-receptor activation induces survival and Bfl-1 expression in human mast cells but not basophils. |
Q40708689 | Inhibition of glucocorticoid-induced apoptosis in 697 pre-B lymphocytes by the mineralocorticoid receptor N-terminal domain |
Q33935219 | Mechanisms underlying hypoxia-induced neuronal apoptosis |
Q33676065 | Meningococcal porin PorB prevents cellular apoptosis in a toll-like receptor 2- and NF-kappaB-independent manner |
Q34993681 | MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2 |
Q35507942 | Minireview: roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathology |
Q24554454 | NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis |
Q24685661 | NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes |
Q36961875 | Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. |
Q38965830 | Paradoxical effects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax expressing cells |
Q35652193 | Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics |
Q36382758 | Regulation of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptor. |
Q46029936 | Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent. |
Q22253852 | Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells |
Q28507595 | The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival |
Q40566546 | The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells |
Q36948716 | The C-terminal domain of A1/Bfl-1 regulates its anti-inflammatory function in human endothelial cells |
Q39592173 | The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line |
Q36295655 | The role of apoptosis in the development and function of T lymphocytes |
Q33881268 | Tissue-specific Bcl-2 protein partners in apoptosis: An ovarian paradigm |
Q42133728 | To live or die: a critical decision for the lung |